RAPT THERAPEUTICS INC (RAPT) Stock Balance Sheet
NASDAQ:RAPT - Nasdaq - US75382E1091 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | N/A | 169.74M | 47.48M | 38.90M | 24.00M | |||
| Marketable Securities | N/A | 61.32M | 111.38M | 210.10M | 165.60M | |||
| Other Current Assets | 3.92M | 4.18M | 2.92M | 3.60M | 3.30M | |||
| Total Current Assets | 183.00M | 235.00M | 162.00M | 252.70M | 193.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.99M | 4.70M | 7.68M | 9.50M | 2.70M | |||
| Other Non-Current Assets | 390.00K | 390.00K | 3.87M | 4.00M | 2.90M | |||
| Total Non-Current Assets | 5.00M | 5.00M | 11.00M | 13.50M | 5.60M | |||
| TOTAL ASSETS | 188.00M | 240.00M | 173.00M | 266.20M | 198.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.24M | 12.00M | 17.00M | 10.80M | 6.30M | |||
| Accounts Payable | 1.30M | 1.28M | 5.18M | 3.40M | 2.00M | |||
| Other Current Liabilities | 140.00K | 35.00M | 110.00K | 0.00 | 1.30M | |||
| Total Current Liabilities | 8.68M | 48.00M | 22.00M | 14.20M | 9.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.52M | 2.07M | 4.46M | 6.80M | 2.70M | |||
| Total Non-Current Liabilities | 1.32M | 2.00M | 4.00M | 6.80M | 2.70M | |||
| TOTAL LIABILITIES | 10.00M | 50.00M | 26.00M | 21.00M | 12.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -632.00M | -615.00M | -485.00M | -367.90M | -284.00M | |||
| Additional Paid In Capital | 809.00M | 804.00M | 632.00M | 613.10M | 470.60M | |||
| Common Shares | 10.00K | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 40.00K | 50.00K | 100.00K | 0.00 | -200.00K | |||
| Shares Outstanding | 132.00M | 132.00M | 34.00M | 34.30M | 29.60M | |||
| Tangible Book Value per Share | N/A | 1.44 | 4.27 | 7.15 | 6.30 | |||
| Total Shareholders' Equity | 177.00M | 190.00M | 147.00M | 245.20M | 186.40M | |||
| TOTAL LIABILITIES AND EQUITY | 188.00M | 240.00M | 173.00M | 266.20M | 198.60M | |||
| Statistics | ||||||||
| Current Ratio | 21.08 | 4.90 | 7.36 | 17.80 | 20.10 | |||
| Return On Assets (ROA) | -61.70% | -54.17% | -67.63% | -31.50% | -34.84% | |||
| Return On Equity (ROE) | -65.54% | -68.42% | -79.59% | -34.19% | -37.12% | |||
All data in USD , ROIC based on taxRate of 0.21